Endothelial cell dysfunction and inflammatory process in type 1 diabetic patients with-and without micro vascular disease

الملخص EN

Endothelial cell dysfunction results in altered production of cell adhesion molecules (CAMs) that may be involved in the pathogenesis of diabetic microvascular disease.

Increased circulating cytokines may also be involved in this process.

The aim of the present study was to evaluate levels of some CAMs and cytokines in children and adolescents with type 1 diabetes.

It was also aimed to assess these parameters in relation to microvascular complications and certain risk factors.

The study included 45 cases with type 1 diabetes aged 8-22 years of whom, 30 cases had evidence of microangiopathy (retinopathy or nephropathy) and 15 cases had not.

Fifteen apparently healthy matchable subjects were included as controls.

Cases were subjected to full history taking and physical examination.

Direct ophthalmoscopy and fluorescein angiography were used to diagnose retinopathy, while nephropathy was diagnosed by detection of microalbuminuria.

Level of glycated hemoglobin (HbA1c) and serum levels of sVCAM-1 and sE-selectin as well as IL-6 and TNF? were assessed for all patients and controls.

The results showed that diabetic patients as a whole had significantly higher serum levels of sVCAM-1, sE-selectin, IL-6 and TNF? than controls.

Post pubertal age, long duration of illness, obesity and high HbA1c level were significant risk factors for higher levels of CAMs.

Significant positive correlations were found between levels of HbA1c and each of serum levels of sE-selectin and IL-6.

Also significant positive correlations were found between each of serum levels of sVCAM-1 and sE-selectin, and IL-6 and TNF?.

Patients with evidence of microangiopathy had significantly higher level of sVCAM-1 than cases without, and the latter group had significantly higher level of sE-selectin than controls.

It is concluded that young patients with type 1 diabetes had significant markers of endothelial cell dysfunction particularly in those with microvascular disease.

Screening of diabetic patients with E-selection may help early diagnosis of endothelial dysfunction.

Strict glycemic control and new therapeutic targets are mandatory to improve diabetic outcome in such cases.